UVA neuroscientist Kevin Pelphrey researches biological markers for autism and discusses the drug that is all over the news.
In a now-completed clinical trial, the stem cell therapy Neuronata-R was found to benefit ALS patients with slower disease ...
SurvivorNet on MSN
FDA Approves New Subcutaneous (Under-the-Skin) Option for Keytruda: What It Means for Cancer Patients
The U.S. Food and Drug Administration (FDA) has approved the subcutaneous form of Keytruda for a new 'Under-the-Skin' Option ...
The medication, also referred to as folinic aid, is a synthetic form of vitamin B9 that requires a prescription.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback